Towards deep-learning based detection and quantification of intestinal metaplasia on digitized gastric biopsies: a
Fabian Cano1, Mauricio Caviedes1, Andres Siabatto1
1Computer Imaging and Medical Applications Laboratory-Cim@lab, Universidad Nacional de Colombia, Bogotá D.C., Colombia.
Abstract:
Current gastric cancer (GCa) risk systems are prone to errors since they evaluate a visual estimation of intestinal metaplasia percentages in histopathology images of gastric mucosa to assign a risk. This study presents an automated method to detect and quantify intestinal metaplasia using deep convolutional neural networks as well as a comparative analysis with visual estimations of three pathologists. Gastric samples were collected from two different cohorts: 149 asymptomatic volunteers from a region with a high prevalence of GCa in Colombia and 56 patients from a tertiary hospital. Deep learning models were trained to classify intestinal metaplasia, and predictions were used to estimate a percentage of intestinal metaplasia and to assign an adapted OLGIM stage. Atrophy was not assessed because of the limited reproducibility among pathologists. Results were compared with independent blinded metaplastic assessments performed by three graduated pathologists. The best-performing deep learning architecture classified intestinal metaplasia with F1-Score of [Formula: see text] and AUC of [Formula: see text]. Among pathologists, inter-observer agreement by a Fleiss's Kappa score ranged from 0.20 to 0.48. In comparison, agreement between the pathologists and the best-performing model ranged from 0.12 to 0.35. Deep learning models show potential to reliably detect and quantify the percentage of intestinal metaplasia, achieving high classification performance. In practice, visual estimation is still the only available method, yet it is marked by considerable inter-observer variability. Deep learning models provide consistent estimates that could help reduce this subjectivity in risk stratification.
Related Concept Videos
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Serum Laboratory Studies, Stool Test, Breath Test
Imaging Studies III: Gastrointestinal Motility Studies and Virtual Colonoscopy
Radionuclide Testing
Radionuclide testing is a sophisticated medical technique for assessing gastrointestinal motility. It focuses on gastric emptying and colonic transit time. Radioactive markers track the movement of food through the digestive system, providing insights into gastrointestinal disorders.
In gastric emptying studies, a meal's liquid and solid...


